BACKGROUND: Genome-wide association studies have identified associations of genetic variants at 17q21 near ORMDL3 with childhood asthma. OBJECTIVES: We sought to determine whether associations in this region are specific to particular asthma phenotypes and specific to ORMDL3. METHODS: We examined associations between 244 independent single nucleotide polymorphisms (SNPs) plus 13 previously identified asthma-related SNPs in the region between 34 and 36 Mb on chromosome 17 and early wheezing phenotypes, doctor-diagnosed asthma and atopy at 7½ years, and bronchial hyperresponsiveness and lung function at 8½ years in 7045 children from the Avon Longitudinal Study of Parents and Children birth cohort study. With this, cis expression quantitative trait loci signals for the same SNPs were assessed in 875 samples across genes in the same region. RESULTS: The strongest evidence for phenotypic association was seen for persistent wheezing (rs8076131 near ORMDL3: relative risk ratio [RRR], 1.60 [95% CI, 1.40-1.84], P = 1.4 × 10(-11); rs2305480 near GSDML: RRR, 1.60 [95% CI, 1.39-1.83], P = 1.5 × 10(-11); and rs9303277 near IKZF3: RRR, 1.57 [95% CI, 1.37-1.79], P = 4.4 × 10(-11)). Similar but less precisely estimated effects were seen for intermediate-onset wheeze, but there was little evidence of associations with other wheezing phenotypes. There was some evidence of associations with bronchial hyperresponsiveness. SNPs across the whole region show strong evidence of association with differential levels of expression at GSDML, IKZF3, and MED24, as well as ORMDL3. CONCLUSIONS: Associations of SNPs in the 17q21 locus are specific to asthma and specific wheezing phenotypes and are not explained by associations with intermediate phenotypes, such as atopy or lung function.
BACKGROUND: Genome-wide association studies have identified associations of genetic variants at 17q21 near ORMDL3 with childhood asthma. OBJECTIVES: We sought to determine whether associations in this region are specific to particular asthma phenotypes and specific to ORMDL3. METHODS: We examined associations between 244 independent single nucleotide polymorphisms (SNPs) plus 13 previously identified asthma-related SNPs in the region between 34 and 36 Mb on chromosome 17 and early wheezing phenotypes, doctor-diagnosed asthma and atopy at 7½ years, and bronchial hyperresponsiveness and lung function at 8½ years in 7045 children from the Avon Longitudinal Study of Parents and Children birth cohort study. With this, cis expression quantitative trait loci signals for the same SNPs were assessed in 875 samples across genes in the same region. RESULTS: The strongest evidence for phenotypic association was seen for persistent wheezing (rs8076131 near ORMDL3: relative risk ratio [RRR], 1.60 [95% CI, 1.40-1.84], P = 1.4 × 10(-11); rs2305480 near GSDML: RRR, 1.60 [95% CI, 1.39-1.83], P = 1.5 × 10(-11); and rs9303277 near IKZF3: RRR, 1.57 [95% CI, 1.37-1.79], P = 4.4 × 10(-11)). Similar but less precisely estimated effects were seen for intermediate-onset wheeze, but there was little evidence of associations with other wheezing phenotypes. There was some evidence of associations with bronchial hyperresponsiveness. SNPs across the whole region show strong evidence of association with differential levels of expression at GSDML, IKZF3, and MED24, as well as ORMDL3. CONCLUSIONS: Associations of SNPs in the 17q21 locus are specific to asthma and specific wheezing phenotypes and are not explained by associations with intermediate phenotypes, such as atopy or lung function.
Authors: Joshua Galanter; Shweta Choudhry; Celeste Eng; Sylvette Nazario; José R Rodríguez-Santana; Jesús Casal; Alfonso Torres-Palacios; Jorge Salas; Rocio Chapela; H Geoffrey Watson; Kelley Meade; Michael LeNoir; William Rodríguez-Cintrón; Pedro C Avila; Esteban González Burchard Journal: Am J Respir Crit Care Med Date: 2008-02-28 Impact factor: 21.405
Authors: Emmanuelle Bouzigon; Eve Corda; Hugues Aschard; Marie-Hélène Dizier; Anne Boland; Jean Bousquet; Nicolas Chateigner; Frédéric Gormand; Jocelyne Just; Nicole Le Moual; Pierre Scheinmann; Valérie Siroux; Daniel Vervloet; Diana Zelenika; Isabelle Pin; Francine Kauffmann; Mark Lathrop; Florence Demenais Journal: N Engl J Med Date: 2008-10-15 Impact factor: 91.245
Authors: Olga E Savenije; Raquel Granell; Daan Caudri; Gerard H Koppelman; Henriëtte A Smit; Alet Wijga; Johan C de Jongste; Bert Brunekreef; Jonathan A Sterne; Dirkje S Postma; John Henderson; Marjan Kerkhof Journal: J Allergy Clin Immunol Date: 2011-03-16 Impact factor: 10.793
Authors: Jeffrey C Barrett; David G Clayton; Patrick Concannon; Beena Akolkar; Jason D Cooper; Henry A Erlich; Cécile Julier; Grant Morahan; Jørn Nerup; Concepcion Nierras; Vincent Plagnol; Flemming Pociot; Helen Schuilenburg; Deborah J Smyth; Helen Stevens; John A Todd; Neil M Walker; Stephen S Rich Journal: Nat Genet Date: 2009-05-10 Impact factor: 38.330
Authors: Clement Oyeniran; Jamie L Sturgill; Nitai C Hait; Wei-Ching Huang; Dorit Avni; Michael Maceyka; Jason Newton; Jeremy C Allegood; Alison Montpetit; Daniel H Conrad; Sheldon Milstien; Sarah Spiegel Journal: J Allergy Clin Immunol Date: 2015-04-02 Impact factor: 10.793
Authors: Brian D Modena; Eugene R Bleecker; William W Busse; Serpil C Erzurum; Benjamin M Gaston; Nizar N Jarjour; Deborah A Meyers; Jadranka Milosevic; John R Tedrow; Wei Wu; Naftali Kaminski; Sally E Wenzel Journal: Am J Respir Crit Care Med Date: 2017-06-01 Impact factor: 21.405
Authors: Cynthia Kanagaratham; Victoria Chiwara; Bianca Ho; Sanny Moussette; Mina Youssef; David Venuto; Lucie Jeannotte; Guillaume Bourque; Juan Bautista de Sanctis; Danuta Radzioch; Anna K Naumova Journal: Mamm Genome Date: 2018-03-13 Impact factor: 2.957
Authors: Ralf Jp van der Valk; Liesbeth Duijts; Nicolas J Timpson; Muhammad T Salam; Marie Standl; John A Curtin; Jon Genuneit; Marjan Kerhof; Eskil Kreiner-Møller; Alejandro Cáceres; Anna Gref; Liming L Liang; H Rob Taal; Emmanuelle Bouzigon; Florence Demenais; Rachel Nadif; Carole Ober; Emma E Thompson; Karol Estrada; Albert Hofman; André G Uitterlinden; Cornélia van Duijn; Fernando Rivadeneira; Xia Li; Sandrah P Eckel; Kiros Berhane; W James Gauderman; Raquel Granell; David M Evans; Beate St Pourcain; Wendy McArdle; John P Kemp; George Davey Smith; Carla Mt Tiesler; Claudia Flexeder; Angela Simpson; Clare S Murray; Oliver Fuchs; Dirkje S Postma; Klaus Bønnelykke; Maties Torrent; Martin Andersson; Patrick Sleiman; Hakon Hakonarson; William O Cookson; Miriam F Moffatt; Lavinia Paternoster; Erik Melén; Jordi Sunyer; Hans Bisgaard; Gerard H Koppelman; Markus Ege; Adnan Custovic; Joachim Heinrich; Frank D Gilliland; Alexander J Henderson; Vincent Wv Jaddoe; Johan C de Jongste Journal: J Allergy Clin Immunol Date: 2013-12-06 Impact factor: 10.793
Authors: Brian Hallmark; Ganesa Wegienka; Suzanne Havstad; Dean Billheimer; Dennis Ownby; Eneida A Mendonca; Lisa Gress; Debra A Stern; Jocelyn Biagini Myers; Gurjit K Khurana Hershey; Lori Hoepner; Rachel L Miller; Robert F Lemanske; Daniel J Jackson; Diane R Gold; George T O'Connor; Dan L Nicolae; James E Gern; Carole Ober; Anne L Wright; Fernando D Martinez Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 21.405
Authors: Catherine Igartua; Rachel A Myers; Rasika A Mathias; Maria Pino-Yanes; Celeste Eng; Penelope E Graves; Albert M Levin; Blanca E Del-Rio-Navarro; Daniel J Jackson; Oren E Livne; Nicholas Rafaels; Christopher K Edlund; James J Yang; Scott Huntsman; Muhammad T Salam; Isabelle Romieu; Raphael Mourad; James E Gern; Robert F Lemanske; Annah Wyss; Jane A Hoppin; Kathleen C Barnes; Esteban G Burchard; W James Gauderman; Fernando D Martinez; Benjamin A Raby; Scott T Weiss; L Keoki Williams; Stephanie J London; Frank D Gilliland; Dan L Nicolae; Carole Ober Journal: Nat Commun Date: 2015-01-16 Impact factor: 14.919